10 Best Promising Stocks For 2014

There's never a dull week on Wall Street. Let's go over some of the news that will shape the week to come.

Monday
The market is closed in observance of Memorial Day. The holiday should provide time to catch a few episodes of the fourth season of Arrested Development that began streaming exclusively through Netflix (NASDAQ: NFLX  ) the day before. This will be the third major piece of original content that Netflix has offered in the past four months.

It's a pity that Netflix doesn't report its monthly churn metric anymore, because it would probably be pretty good as the steady inflow of new shows keeps subscribers close.

Tuesday
Perfect World (NASDAQ: PWRD  ) logs in with its quarterly results on Tuesday.

Online gaming is hot in China, but Perfect World has seen better days. Analysts see revenue sliding 15% for the quarter, with earnings taking an even bigger 46% hit. Despite the uninspiring fundamentals, shares of Perfect World did hit a fresh 52-week high this past week. There are some potentially promising games in the pipeline, so clearly the market thinks Perfect World will turn things around.

Hot International Companies To Buy Right Now: Volcano Corporation(VOLC)

Volcano Corporation designs, develops, manufactures, and commercializes intravascular ultrasound (IVUS) and fractional flow reserve (FFR) products used in the diagnosis and treatment of vascular and structural heart disease. It offers multi-modality consoles, which are marketed as stand-alone units that can be integrated into hospital-based interventional surgical suites, such as catheterization laboratories. The company provides IVUS products, including single-procedure disposable phased array and rotational IVUS imaging catheters; and additional functionality options comprising virtual histology tissue characterization, and ChromaFlo stent apposition analysis. It also offers FFR products, such as pressure and flow consoles, and single-procedure disposable pressure and flow guide wires used to measure the pressure and flow characteristics of blood around plaque enabling physicians to gauge the plaque?s physiological impact on blood flow and pressure. In addition, the com pany develops and manufactures optical monitors for the telecommunication industry; laser and non-laser light sources; optical engines used in the medical OCT imaging systems and advanced photonic components; and sub-systems used in spectroscopy and other industrial applications. Its products under development include image-guided therapy device and micro and thrombectomy catheters. The company?s ongoing clinical studies comprise assessment of dual anti-platelet therapy with drug-eluting stents; vascular evaluation for revascularization; fractional flow reserve and intravascular ultrasound relationship study; adensonine vasodilation independent stenosis evaluation; and evaluation of XIENCE PRIME. It sells its products through direct sales force and distributors, as well as through third parties supply and distribution agreements primarily in the United States, Japan, Europe, the Middle East, Africa, and internationally. The company was founded in 2000 and is headquartered i n San Diego, California.

Advisors' Opinion:

• [By Ben Levisohn]

  Instead of an eruption, Volcano (VOLC) got an earnings-induced collapse instead.

  Associated Press

  Medical-device maker Volcano said its third quarter profit would miss Wall Street forecasts, and 2013 sales would also disappoint. And 2014? Well, that didn’t look too exciting other.

  JPMOrgan analyst Christopher Pasquale and team have had enough:

  We are downgrading VOLC shares to Neutral from Overweight following the company�� negative 3Q preannouncement and disappointing initial 2014 growth outlook Monday after the close. While we continue to see significant long-term potential for Volcano�� technologies, we are concerned by persistent headwinds to its core IVUS franchise and slowing FFR growth. With our conviction in a pipeline-driven reacceleration reduced and visibility into meaningful new growth drivers unlikely for several quarters, we are moving to the sidelines.

  Canaccord Genuity’s Jason Mills and Jeffrey Chu also cut Volcano to Hold–just a quarter after upgrading it–and even today’s drop might not make it worth buying. They explain why:

  Our upgrade of VOLC last quarter was predicated on the improving trends in the core IVUS business, FFR continuing as a long-term growth engine, and the potential material gross margin expansion. While Q3 results included pockets of good news, adverse trends predominated.
  While US IVUS rebounded modestly, driven by peripheral IVUS (+40% Y/Y), IVUS and FM results in Japan were very disconcerting to us (-19%, +8%, respectively), and portend share loss, in our estimation. Also, while we still expect significant gross margin expansion long term, it seems we may have to wait longer than expected.

  In sum, we would not aggressively buy weakness unless the stock is over-penalized on these results – i.e. below $20.

  While shares of Volcano have dropped 15% to $20.74, large-cap medical device companies are having a solid day. Boston Scienti

10 Best Promising Stocks For 2014: iShares MSCI Spain Capped ETF (ISVS)

iShares MSCI Spain Index Fund (the Fund) seeks to provide investment results that correspond generally to the price and yield performance of publicly traded securities in the aggregate in the Spanish market, as measured by the MSCI Spain Index (the Index). The Index seeks to measure the performance of the Spanish equity market. The Index is a capitalization-weighted index that aims to capture 85% of the (publicly available) total market capitalization. Component companies are adjusted for available float and must meet objective criteria for inclusion in the Index. The Index is reviewed quarterly.

The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Fund�� investment advisor is Barclays Global Fund Advisors.

Advisors' Opinion:

• [By abirk]

  This San Jose, Calif.-based company offers a line of software and services used by professionals, marketers, knowledge workers, application developers, enterprises and consumers for creating, managing, delivering, measuring and engaging with content and experiences across multiple operating systems, devices and media. Adobe has three business segments: Digital Media, Digital Marketing, and Print and Publishing. The company distributes its products through a network of distributors, value-added resellers (VARs), systems integrators, independent software vendors (ISVs), retailers, and original equipment manufacturers (OEMs).

• [By abirk]

  This San Jose, Calif.-based company offers a line of software and services used by professionals, marketers, knowledge workers, application developers, enterprises and consumers for creating, managing, delivering, measuring and engaging with content and experiences across multiple operating systems, devices and media. Adobe has three business segments: Digital Media, Digital Marketing, and Print and Publishing. The company distributes its products through a network of distributors, value-added resellers (VARs), systems integrators, independent software vendors (ISVs), retailers, and original equipment manufacturers (OEMs).

10 Best Promising Stocks For 2014: Autodesk Inc.(ADSK)

Autodesk, Inc. provides design software and services to customers worldwide. Its Platform Solutions and Emerging Business segment offers AutoCAD software, a customizable and extensible computer-aided design (CAD) application for professional design, drafting, detailing, and visualization in fields ranging from construction to manufacturing, civil engineering, and process plant design; and AutoCAD LT, a professional drafting and detailing software that includes document sharing capability. The company?s Architecture, Engineering and Construction segment offers Autodesk Revit products, which provide model-based design and documentation system for architects, structural engineers, and design-build teams, as well as mechanical, electrical, and plumbing engineers; AutoCAD Civil 3D products, which provide a surveying, design, analysis, and documentation solution for civil engineering; AutoCAD Architecture software that includes architecture industry-specific tools to improve co ordination; and AutoCAD Map 3D software, which provides direct access to data needed for infrastructure planning, design, and management activities. Autodesk, Inc.?s Manufacturing segment?s products comprise Autodesk Inventor, which offers engineers a set of tools for 3D mechanical design, simulation, analysis, tooling, visualization, and documentation; AutoCAD Mechanical software that accelerates the mechanical design process; and Autodesk Moldflow, which provides tools that help manufacturers optimize the design of plastic parts and injection molds, and study the injection molding process. Its Media and Entertainment segment offers animation products that provide tools for digital sculpting, modeling, animation, effects, rendering, and compositing; and creative finishing products that provide editing, finishing, and visual effects design and color grading. The company also offers design and creation suites. Autodesk, Inc. was founded in 1982 and is headquartered in San R afael, California.

Advisors' Opinion:

• [By Geoffrey Seiler]

  While this transition can lead to lumpy results, the market has embraced other firms that have made this transition, such as Adobe (ADBE) and Autodesk (ADSK).

• [By Markus Aarnio]

  Autodesk (ADSK) operates as a design software and services company worldwide. Its Platform Solutions and Emerging Business segment offers AutoCAD software.

• [By Teresa Rivas]

  As for companies with the most upside, Marathon Petroleum (MPC) tops the list, with 63.6%, followed by Autodesk (ADSK), Ventas (VTR), salesforce.com (CRM) and American Tower (AMT). Outside the top five, the list also includes big names like Schlumberger (SLB), Halliburton (HAL), Expedia (EXPE) and General Motors (GM).

• [By Erin McCarthy]

  Autodesk Inc.(ADSK) said its fiscal first-quarter earnings fell 49% as higher costs offset the design-software company’s revenue growth, though adjusted earnings and revenue beat expectations.

10 Best Promising Stocks For 2014: Texas Roadhouse Inc.(TXRH)

Texas Roadhouse, Inc., together with its subsidiaries, operates a full-service casual dining restaurant chain. It operates restaurants under the Texas Roadhouse and Aspen Creek names. The company also provides supervisory and administrative services for other license and franchise restaurants. As of December 27, 2011, it owned and operated 294 restaurants; and franchised and licensed an additional 72 restaurants in 47 states in the United States, and Dubai, the United Arab Emirates. The company was founded in 1993 and is based in Louisville, Kentucky.

Advisors' Opinion:

• [By Seth Jayson]

  When judging a company's prospects, how quickly it turns cash outflows into cash inflows can be just as important as how much profit it's booking in the accounting fantasy world we call "earnings." This is one of the first metrics I check when I'm hunting for the market's best stocks. Today, we'll see how it applies to Texas Roadhouse (Nasdaq: TXRH  ) .

• [By Marc Bastow]

  Full service restaurant group Texas Roadhouse (TXRH) raised its quarterly dividend 25% to 15 cents per share, payable April 4 to shareholders of record as of March 19.
  TRXH Dividend Yield: 2.25%

• [By Seth Jayson]

  Texas Roadhouse (Nasdaq: TXRH  ) is expected to report Q2 earnings on July 29. Here's what Wall Street wants to see:

  The 10-second takeaway
  Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Texas Roadhouse's revenues will grow 10.7% and EPS will increase 3.6%.

10 Best Promising Stocks For 2014: L&L Energy Inc.(LLEN)

L&L Energy, Inc., through its subsidiaries, engages in the coal mining, clean coal washing, coal coking, and coal wholesaling businesses in the People?s Republic of China. It involves in producing, processing, and selling metallurgical coke used primarily for steel manufacturing; and crushing coal and washing out soluble sulfur compounds with water or other solvents. The company has four coal mines comprising the DaPuAn, SuTsong, Ping Yi, and DaPing mines; three coal washing plants; one coking facility; and coal wholesale and distribution facilities. It also has a financial interest in the Bowie mine, a thermal coal mine located in Paonia, Colorado. The company provides its products to customers in the steel and the electrical/utility industries, as well as to cement factories. L&L Energy, Inc. sells its products directly and through third-party wholesalers. The company was formerly known as L & L International Holdings, Inc. and changed its name to L&L Energy, Inc. in Jan uary 2010. L&L Energy, Inc. was founded in 1995 and is headquartered in Seattle, Washington.

Advisors' Opinion:

• [By Monica Gerson]

  Breaking news

  Alcoa (NYSE: AA) is investing US$13 million to expand its wheel manufacturing plant in Europe, to meet growing demand for its lightweight, durable, low-maintenance aluminum truck wheels. To read the full news, click here. L & L Energy (NASDAQ: LLEN) announced today that its Special Independent Committee has appointed Mr. Nicholas Chen, Managing Partner at Pamir Law Group, to replace Mr. Mark Bartlett. To read the full news, click here. Five Prime Therapeutics (NASDAQ: FPRX) and Bristol-Myers Squibb (NYSE: BMY) announced today that they have signed a collaboration agreement for the discovery, development and commercialization of immuno-oncology therapies directed toward targets identified in two undisclosed immune checkpoint pathways using Five Prime's proprietary target discovery platform. To read the full news, click here. First Solar (NASDAQ: FSLR) on Sunday announced the completion of the 1.3MW(DC) solar photovoltaic (PV) power plant at Kitakyushu-shi. Powered by First Solar FS Series 3 Black PV modules, the plant will generate approximately 1,400 MWh of clean and safe solar electricity per year. To read the full news, click here.

  Posted-In: Credit Suisse US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

• [By James E. Brumley]

  Well, as it turns out, the snake that bit L&L Energy, Inc. (NASDAQ:LLEN) and Sovereign Lithium Inc. (OTCMKTS:SLCO) didn't end up biting Makism 3D Corp. (OTCMKTS:MDDD). And in retrospect, that's probably how it should be. Indeed, the fact that MDDD didn't even come close to suffering the same fate as SLCO or LLEN did may be the biggest assurance Makism 3D fans could hope for that the company is everything it says it is.

• [By James E. Brumley]

  Despite every fiber of my being telling me to not get involved in the schoolyard fight between L&L Energy, Inc. (NASDAQ:LLEN) and apparently one of its enemies (that just so happens to have a short/bearish position in LLEN), I find myself unable to not sound off. A sane and unbiased observation has to be injected into the mix here.

10 Best Promising Stocks For 2014: Chelsea Therapeutics International Ltd.(CHTP)

Chelsea Therapeutics International, Ltd., a development-stage pharmaceutical company, focuses on the acquisition, development, and commercialization of therapeutic products for the treatment of various human diseases. It is involved in developing Droxidopa, a therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension (NOH) associated with primary autonomic failure and falls related to NOH in Parkinson?s Disease (PD), as well as other norepinephrine-related conditions and diseases, including intradialytic hypotension, fibromyalgia, adult attention deficit hyperactivity disorder, chronic fatigue syndrome, and freezing of gait in PD and down syndrome. The company intends to market its Droxidopa drug under the Northera brand name. It also engages in developing a portfolio of molecules for the treatment of various autoimmune/inflammatory diseases, including rheumatoid arthritis, psoriasis, Crohn?s disease, ankylosing spondylitis, uveitis, psoriatic arthritis, inflammatory bowel disease, cancer, and other immunological disorders. The company?s molecule products include a portfolio of metabolically inert antifolate molecules consisting of CH-1504 and CH-4051, which are orally available molecules with anti-inflammatory, autoimmune, and anti-tumor properties that inhibit various key enzymes required for cell proliferation; and a portfolio of dihydroorotate dehydrogenase, known as the I-3D portfolio, for applications in autoimmune diseases and transplantation. Chelsea Therapeutics International, Ltd. was founded in 2002 and is headquartered in Charlotte, North Carolina.

Advisors' Opinion:

• [By Jon C. Ogg]

  Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) is finding a serious victory from its hypotension drug. Shares hit a 52-week high — make that a three-year high — after the company confirmed an accelerated FDA approval of its Northera for the treatment of low blood pressure, following FDA panel backing just last month.

• [By Bryan Murphy]

  What do Chelsea Therapeutics International Ltd. (NASDAQ:CHTP), National Bank of Greece (NYSE:NBG), and Walter Energy, Inc. (NYSE:WLT) have in common. They all have charts worth a much closer look right now. That's not to say they're all dropping the same bullish hint. In fact, WLT, NBG, and CHTP are all dropping distinctly-different hints as to their likely near-term future. But, trading action is trading action no matter which direction it's in. Take a look.
  
  Yes: Truth be told, shares of the National Bank of Greece have been working on a rally for a while. It's only been recently, however, that NBG has made it clear it's not going to give up. The stock crossed above the 100-day moving average line (gray) early in the month, and has continued to peel away. Yes, National Bank of Greece hit something of a soft patch last week, but the 20-day moving average line (blue) has since stepped up to the plate as a technical floor, rekindling the uptrend yesterday day and today. Perhaps most bullish of all is the fact that NBG has started to increase volume on the way up, after it cleared the 100-day moving average line,

• [By John Udovich]

  The biotech roller-coaster continues for investors into 2014 with small cap Chelsea Therapeutics International Ltd (NASDAQ: CHTP) set to more than double when the market opens today, meaning its time to take a closer look at what in the world is going on with the stocks plus take a closer look at the performance of biotech peers like the iShares NASDAQ Biotechnology Index ETF (NASDAQ: IBB) and SPDR S&P Biotech ETF (NYSEARCA: XBI).

• [By MONEYMORNING]

  The FDA is scheduled to make a decision on Chelsea's drug, Northera, on Feb. 14.

  Chelsea's (CHTP) Northera Drug

  Northera is used to treat patients with neurogenic orthostatic hypotension (nOH), a rare, lingering type of low blood pressure. nOH typically occurs upon standing and is commonly experienced by those with certain neurological disorders, including Parkinson's disease. Nearly 300,000 patients presently suffer from nOH in the U.S. and EU combined.

10 Best Promising Stocks For 2014: Nuveen Municipal Value Fund Inc.(NUV)

Nuveen Municipal Value Fund, Inc. is a closed-ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is managed by Nuveen Asset Management. It invests in the fixed income markets of the United States. The fund also invests some portion of its portfolio in derivative instruments. It invests in undervalued municipal securities and other related investments the income, exempt from regular federal income taxes that are rated Baa or BBB or better. It employs fundamental analysis with bottom-up stock picking approach to create its portfolio. The fund benchmarks the performance of its portfolio against the Standard & Poor?s (S&P) National Municipal Bond Index. Nuveen Municipal Value Fund, Inc. was formed on April 8, 1987 and is domiciled in the United States.

Advisors' Opinion:

• [By Adam Aloisi]

  The following chart takes a comparative look at some widely held ETFs/CEFs holding different types of bonds. The objective is to visualize not only how much these products cost, but also to break down the percent of total yield depleted by management fees. I define total yield as current annualized yield plus net fees - in other words the yield of the fund if there were no management fees attached. The funds we will examine are aforementioned BND, iShares 20+ Treasury Bond (TLT), iShares High-Yield Corporate (HYG), Nuveen Municipal Value (NUV), Eaton Vance Limited Duration (EVV) and Alliance Bernstein Global High-Yield (AWF).

• [By Aaron Levitt]

  Everyone hates paying taxes. So when investors have the ability to get a 7.3% taxable-equivalent yield, they should jump at the opportunity. As one of the largest and oldest municipal CEFs, the Nuveen Municipal Value Fund (NUV) makes it possible.